Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.900
+0.050 (1.75%)
At close: Apr 28, 2026, 4:00 PM EDT
2.810
-0.090 (-3.10%)
After-hours: Apr 28, 2026, 6:17 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $68.76 million as of April 28, 2026. Its market cap has decreased by -50.48% in one year.
Market Cap
68.76M
Enterprise Value
54.42M
1-Year Change
-50.48%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $68.76M, a decrease of -54.80%. That is a compound annual growth rate of -37.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 67.58M | -52.49% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortress Biotech | 73.10M |
| Acrivon Therapeutics | 72.84M |
| Estrella Immunopharma | 71.68M |
| Impact BioMedical | 71.16M |
| Seres Therapeutics | 70.17M |
| MediciNova | 67.43M |
| Immutep | 66.75M |
| Annovis Bio | 65.27M |